ifa systems (IS8) Stock Overview
Develops clinic and practice software for ophthalmology worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
IS8 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
ifa systems AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.00 |
| 52 Week High | €2.90 |
| 52 Week Low | €1.60 |
| Beta | 0.62 |
| 1 Month Change | -11.50% |
| 3 Month Change | -6.54% |
| 1 Year Change | -13.04% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -16.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| IS8 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -1.7% |
| 1Y | -13.0% | 12.6% | -0.6% |
Return vs Industry: IS8 underperformed the German Healthcare Services industry which returned 12.6% over the past year.
Return vs Market: IS8 underperformed the German Market which returned -0.6% over the past year.
Price Volatility
| IS8 volatility | |
|---|---|
| IS8 Average Weekly Movement | 8.9% |
| Healthcare Services Industry Average Movement | 6.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in DE Market | 13.4% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: IS8's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: IS8's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 47 | Holger Rambach | www.ifasystems.de |
ifa systems AG develops clinic and practice software for ophthalmology worldwide. It offers practice software, such as ifaNX, an eye information system for close dialogue with ophthalmologists and ophthalmic specialists; ifaLION for entering findings, prescribing medications, coding directly in the electronic patient record, and transfering measurement data from devices; and NEXUS / RVC, an optimized data management product. The company also provides NEXUS / AEMP, an IT-supported sterile supply product; NEXUS / CURATOR, a quality management for practice and clinic product; NEXUS / DUTY ROSTER, a deployment planning product; NEXUS / PEGASOS, an archive and ECM for medicine and administration product; and NEXUS / CLOUD IT for knowledge and infrastructure IT services.
ifa systems AG Fundamentals Summary
| IS8 fundamental statistics | |
|---|---|
| Market cap | €5.50m |
| Earnings (TTM) | €175.00k |
| Revenue (TTM) | €6.87m |
Is IS8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IS8 income statement (TTM) | |
|---|---|
| Revenue | €6.87m |
| Cost of Revenue | €1.41m |
| Gross Profit | €5.46m |
| Other Expenses | €5.29m |
| Earnings | €175.00k |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.064 |
| Gross Margin | 79.47% |
| Net Profit Margin | 2.55% |
| Debt/Equity Ratio | 0% |
How did IS8 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/28 08:44 |
| End of Day Share Price | 2026/06/26 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ifa systems AG is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rüdiger Holzammer | BankM AG |
| Ian Robertson | Edison Investment Research |